Pharmaceuticals and Biotechnologies
Pharmaceuticals and Biotechnology
Partnering with U.S. and global Life Sciences companies to manage risk and compliance, optimize quality and maximize performance.
For more than two decades, pharmaceutical and biologic companies around the world have trusted UL PURE™ Learning technologies, training curriculum and regulatory advisory services.
More than a decade ago, the FDA adopted our ComplianceWire® learning and regulatory platform to train their employees to achieve investigator proficiency in a variety of compliance categories.
Through CRADA, the FDA uses UL’s ComplianceWire®
learning platform and regulatory courses to train its 36,000 investigators.
Our compliance training solutions integrate four critical components designed to protect and optimize Life Sciences enterprises—from multinational industry leaders to privately-held entrepreneurial start-ups.
Enterprise LMS (ELMS) - Our web-based employee training, performance and development platform, powered by ComplianceWire®, specifically supports Life Sciences organizations using a highly configurable, role-based Adaptive UX. This globally-recognized system provides brand-specific flexibility to support the unique needs of training administrators, managers and learners at all levels.
UL Create - UL’s self-authoring tool puts you in control of training program design, content and updates helping you tailor eLearning courseware that speaks specifically to your company’s users.
Professional Services - UL's Professional Services deliver far more than LMS implementation; we partner with U.S. and global pharmaceutical and biotechnology clients to help them define, develop, implement and measure successful and sustainable learning programs in a regulated environment.
eLearning Training Courses - Peruse our proprietary library of more than 200 edit-friendly, technically-sound and mobile-ready eLearning courses designed specifically for the Life Sciences industry.
Protecting Your Products in a New Era of Regulatory Restrictions
Without question, the pharmaceutical and biotech industries face an increasing array of barriers to the marketplace, including a continuum of QMS audits, and accelerating clinical site qualifications.
Understanding and meeting the shifting mountain of FDA regulatory compliance requirements, including 21 CFR part 211; part 210; part 820 and 21 CFR Part 11; and EC/EU/ISO regulatory, can delay product launch, offset profits and delay critical product delivery to market.
Spearheading Biotech and Pharma Products Quickly and Safely to Market
UL PURE™ Learning creates regulatory clarity and supports the responsible design, production, marketing and purchase of the goods, solutions, and innovations of today and tomorrow. We connect people to safer, more secure and more sustainable products, services, experiences, and environments – enabling smarter choices leading to living better lives.
Through industry-leading eLearning solutions, we help pharma and biotech organizations drive results in compliance, QA and organizational performance so they can successfully compete in this new marketplace, and lead those industries by introducing new products and services to keep people well or make them better.
We welcome an opportunity to address your company’s training needs, help minimize regulatory risk, achieve compliance, ensure quality assurance and accelerate learner productivity.
To learn more, complete the form to the right or reach out to us at +1-609-627-5300.